TD Cowen Sticks to Its Buy Rating for Iovance Biotherapeutics (IOVA)
In a report released today, Tyler Van Buren from TD Cowen maintained a Buy rating on Iovance Biotherapeutics (IOVA – Research Report).
snmjournals.org6h
Precision Oncology in Melanoma: Changing Practices
Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...
Instil Bio (TIL) Gets a Hold from JMP Securities
In a report released today, Reni Benjamin from JMP Securities reiterated a Hold rating on Instil Bio (TIL – Research Report). The ...